trending Market Intelligence /marketintelligence/en/news-insights/trending/0jw4_leqi1uzbvuz48ijog2 content esgSubNav
In This List

Verastem prices $35M common stock offering

Blog

Baird Research is Now Exclusively Available in S&P Global’s Aftermarket Research Collection

Blog

Japan M&A By the Numbers: Q4 2023

Blog

Essential IR Insights Newsletter Fall - 2023

Case Study

A Corporation Clearly Pinpoints Activist Investor Activity


Verastem prices $35M common stock offering

Verastem Inc. will raise gross proceeds of $35 million via a public offering of 7,777,778 shares.

The biotechnology company priced its shares at $4.50 apiece and also granted the underwriters an option to purchase an additional 1,166,666 shares.

The offering is expected to close May 18, subject to customary closing conditions.

Cantor Fitzgerald & Co. is acting as sole book-running manager for the offering.

Needham, Mass.-based Verastem is a biopharmaceutical company focused on discovering and developing drugs for the treatment of cancer.